> top > docs > PubMed:17975693 > annotations

PubMed:17975693 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
4530 0-10 DiseaseOrPhenotypicFeature denotes Anxiogenic MESH:D001008
4531 24-37 ChemicalEntity denotes ciprofloxacin MESH:D002939
4532 42-53 ChemicalEntity denotes norfloxacin MESH:D009643
4533 57-61 OrganismTaxon denotes rats NCBITaxon:10116
4534 90-100 DiseaseOrPhenotypicFeature denotes anxiogenic MESH:D001008
4535 112-128 ChemicalEntity denotes fluoroquinolones MESH:D024841
4536 137-150 ChemicalEntity denotes ciprofloxacin MESH:D002939
4537 155-166 ChemicalEntity denotes norfloxacin MESH:D009643
4538 217-221 OrganismTaxon denotes rats NCBITaxon:10116
4539 595-608 ChemicalEntity denotes ciprofloxacin MESH:D002939
4540 614-625 ChemicalEntity denotes norfloxacin MESH:D009643
4541 634-638 OrganismTaxon denotes rats NCBITaxon:10116
4542 646-663 DiseaseOrPhenotypicFeature denotes anxious behaviour MESH:D001008
4543 689-693 OrganismTaxon denotes rats NCBITaxon:10116
4544 734-747 ChemicalEntity denotes ciprofloxacin MESH:D002939
4545 753-764 ChemicalEntity denotes norfloxacin MESH:D009643
4546 773-777 OrganismTaxon denotes rats NCBITaxon:10116
4547 941-951 DiseaseOrPhenotypicFeature denotes anxiogenic MESH:D001008
4548 965-978 ChemicalEntity denotes ciprofloxacin MESH:D002939
4549 983-994 ChemicalEntity denotes norfloxacin MESH:D009643

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-62 Sentence denotes Anxiogenic potential of ciprofloxacin and norfloxacin in rats.
T2 63-76 Sentence denotes INTRODUCTION:
T3 77-256 Sentence denotes The possible anxiogenic effects of fluoroquinolones, namely ciprofloxacin and norfloxacin, were investigated in adult Charles Foster albino rats of either sex, weighing 150-200 g.
T4 257-265 Sentence denotes METHODS:
T5 266-394 Sentence denotes The drugs were given orally, in doses of 50 mg/kg for five consecutive days and the experiments were performed on the fifth day.
T6 395-559 Sentence denotes The tests included open-field exploratory behaviour, elevated plus maze and elevated zero maze, social interaction and novelty-suppressed feeding latency behaviour.
T7 560-568 Sentence denotes RESULTS:
T8 569-724 Sentence denotes The results indicate that ciprofloxacin- and norfloxacin-treated rats showed anxious behaviour in comparison to control rats in all the parameters studied.
T9 725-857 Sentence denotes However, ciprofloxacin- and norfloxacin-treated rats did not differ significantly from each other in various behavioural parameters.
T10 858-869 Sentence denotes CONCLUSION:
T11 870-995 Sentence denotes The present experimental findings substantiate the clinically observed anxiogenic potential of ciprofloxacin and norfloxacin.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 57-61 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T4 217-221 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T7 634-638 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T10 689-693 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114
T13 773-777 OrganismTaxon denotes rats NCBItxid:10118|NCBItxid:10116|NCBItxid:10114

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 210-216 GeneOrGeneProduct denotes albino
T2 257-264 GeneOrGeneProduct denotes METHODS
T3 310-312 GeneOrGeneProduct denotes mg
T4 399-404 GeneOrGeneProduct denotes tests
T5 414-418 GeneOrGeneProduct denotes open
T6 462-466 GeneOrGeneProduct denotes maze
T7 485-489 GeneOrGeneProduct denotes maze
T8 491-497 GeneOrGeneProduct denotes social
T9 697-700 GeneOrGeneProduct denotes all
T10 817-822 GeneOrGeneProduct denotes other
T11 895-903 GeneOrGeneProduct denotes findings

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 210-216 GeneOrGeneProduct denotes albino
T2 817-822 GeneOrGeneProduct denotes other

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 0-10 DiseaseOrPhenotypicFeature denotes Anxiogenic DISEASE
T2 90-100 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE
T3 646-663 DiseaseOrPhenotypicFeature denotes anxious behaviour DISEASE
T4 941-951 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 0-10 DiseaseOrPhenotypicFeature denotes Anxiogenic DISEASE
T2 90-100 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE
T3 646-663 DiseaseOrPhenotypicFeature denotes anxious behaviour DISEASE
T4 941-951 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 24-37 ChemicalEntity denotes ciprofloxacin D002939|http://purl.obolibrary.org/obo/CHEBI_100241
T3 42-53 ChemicalEntity denotes norfloxacin D009643|http://purl.obolibrary.org/obo/CHEBI_100246
T5 112-128 ChemicalEntity denotes fluoroquinolones D024841|ChemicalEntity
T7 137-150 ChemicalEntity denotes ciprofloxacin D002939|http://purl.obolibrary.org/obo/CHEBI_100241
T9 155-166 ChemicalEntity denotes norfloxacin D009643|http://purl.obolibrary.org/obo/CHEBI_100246
T11 595-608 ChemicalEntity denotes ciprofloxacin D002939|http://purl.obolibrary.org/obo/CHEBI_100241
T13 614-625 ChemicalEntity denotes norfloxacin D009643|http://purl.obolibrary.org/obo/CHEBI_100246
T15 734-747 ChemicalEntity denotes ciprofloxacin D002939|http://purl.obolibrary.org/obo/CHEBI_100241
T17 753-764 ChemicalEntity denotes norfloxacin D009643|http://purl.obolibrary.org/obo/CHEBI_100246
T19 965-978 ChemicalEntity denotes ciprofloxacin D002939|http://purl.obolibrary.org/obo/CHEBI_100241
T21 983-994 ChemicalEntity denotes norfloxacin D009643|http://purl.obolibrary.org/obo/CHEBI_100246

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 57-61 OrganismTaxon denotes rats
T2 217-221 OrganismTaxon denotes rats
T3 634-638 OrganismTaxon denotes rats
T4 689-693 OrganismTaxon denotes rats
T5 773-777 OrganismTaxon denotes rats

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T21 983-994 ChemicalEntity denotes norfloxacin http://purl.obolibrary.org/obo/CHEBI_100246|D009643
T19 965-978 ChemicalEntity denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241|D002939
T17 753-764 ChemicalEntity denotes norfloxacin http://purl.obolibrary.org/obo/CHEBI_100246|D009643
T15 734-747 ChemicalEntity denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241|D002939
T13 614-625 ChemicalEntity denotes norfloxacin http://purl.obolibrary.org/obo/CHEBI_100246|D009643
T11 595-608 ChemicalEntity denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241|D002939
T9 155-166 ChemicalEntity denotes norfloxacin http://purl.obolibrary.org/obo/CHEBI_100246|D009643
T7 137-150 ChemicalEntity denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241|D002939
T5 112-128 ChemicalEntity denotes fluoroquinolones ChemicalEntity|D024841
T3 42-53 ChemicalEntity denotes norfloxacin http://purl.obolibrary.org/obo/CHEBI_100246|D009643
T1 24-37 ChemicalEntity denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241|D002939
T4 941-951 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE
T43713 646-663 DiseaseOrPhenotypicFeature denotes anxious behaviour DISEASE
T2 90-100 DiseaseOrPhenotypicFeature denotes anxiogenic DISEASE
T40980 0-10 DiseaseOrPhenotypicFeature denotes Anxiogenic DISEASE
T98755 773-777 OrganismTaxon denotes rats
T32331 689-693 OrganismTaxon denotes rats
T69457 634-638 OrganismTaxon denotes rats
T68161 217-221 OrganismTaxon denotes rats
T53721 57-61 OrganismTaxon denotes rats

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 210-216 HP_0001022 denotes albino